Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M116Revenue $M17.9Net Margin (%)-65.4Z-Score-5.5
Enterprise Value $M104EPS $-0.2Operating Margin %-60.5F-Score3
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-65.1Higher ROA y-yN
Price/Book10.310-y EBITDA Growth Rate %0Quick Ratio4.4Cash flow > EarningsY
Price/Sales7.55-y EBITDA Growth Rate %-40.6Current Ratio4.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-68.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-159.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M54.5ROI % (ttm)-32.3Gross Margin Increase y-yN

Gurus Latest Trades with PIP

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

PIP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PIP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Runge Jeffrey W.Director 2011-12-12Buy20,000$1.358.46 view
FUERST THOMAS RICHARDSVP, Chief Scientific Officer 2011-11-22Buy5,000$1.2762.2 view
CHANG LINDA LSVP & CFO 2011-11-16Buy10,000$1.3849.28 view
SAYARE MITCHELDirector 2011-08-18Buy5,000$2.17-5.07 view
Riddle Valerie DSVP, Medical Director 2011-05-31Sell13,567$3.92-47.45 view
PAPPAJOHN JOHNDirector 2011-05-25Sell50,000$3.68-44.02 view
Riddle Valerie DSVP, Medical Director 2011-05-23Sell8,791$3.65-43.56 view
SCHAFFER DERACE LDirector 2011-05-19Sell267,497$3.69-44.17 view
MPM BIOVENTURES III LLC10% Owner 2010-11-03Buy430,000$3.5-41.14 view
EVNIN LUKE10% Owner 2010-11-03Buy430,000$3.5-41.14 view

Press Releases about PIP :

    Quarterly/Annual Reports about PIP:

    News about PIP:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: BWEN, ENZ, PIP, HAFC, AACC Nov 21 2011 
    PharmAthene Inc (PIP) CEO Eric I Richman buys 10,000 Shares Jun 21 2010 
    Guru Activities for Today’s Price % Losers: PharmAthene Inc. , Authentidate Holding Corp., Kroger Dec 08 2009 


    More From Other Websites
    PHARMATHENE, INC Financials Aug 15 2014
    Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% Aug 14 2014
    PharmAthene May Get $500 Million From Smallpox Drug Sales Aug 12 2014
    Why SIGA Technologies (SIGA) Stock Plunged to a One-Year Low Today Aug 11 2014
    Why PharmAthene (PIP) Stock Is Soaring Today Aug 11 2014
    Why PharmAthene Is Up 56% In #PreMarket Trading Aug 11 2014
    [$$] Court Rules in PharmAthene's Favor Aug 11 2014
    PHARMATHENE, INC Files SEC form 8-K, Other Events Aug 11 2014
    Delaware Court of Chancery Orders SIGA To Pay PharmAthene Lump Sum Expectation Damages Aug 10 2014
    Q2 2014 PharmAthene, Inc. Earnings Release- Tentative - Time Not Supplied Aug 07 2014
    PHARMATHENE, INC Files SEC form 10-Q, Quarterly Report Aug 05 2014
    PharmAthene Reports Second Quarter 2014 Financial And Operational Results Aug 04 2014
    PHARMATHENE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 04 2014
    PharmAthene Reports Second Quarter 2014 Financial And Operational Results Aug 04 2014
    PharmAthene Vs. SIGA: Rebutting G. Hudson's 'Potential Award' Article Jul 24 2014
    Explanation Of Potential Damage Award In PharmAthene Versus Siga Lawsuit Jul 22 2014
    PHARMATHENE, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 12 2014
    PharmAthene announces U.S. patent for recombinant bioscavenger Jun 09 2014
    PharmAthene Granted U.S. Patent For Recombinant Bioscavenger Jun 09 2014
    PharmAthene Presents New SparVax® Anthrax Vaccine Data At The FDA Medical Countermeasures... Jun 04 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide